New Delhi, April 04: India’s President Droupadi Murmu, marked a historic milestone today as she unveiled the nation’s inaugural homegrown gene therapy for cancer at the esteemed IIT Bombay. It heralds a significant stride in India’s fight against cancer.
In her address, President Murmu hailed the launch of India’s first gene therapy as a pivotal breakthrough in combating cancer. Named “CAR-T cell therapy,” this innovative treatment offers accessibility and affordability, instilling fresh hope for humanity. The President exuded confidence in its potential to breathe new life into countless patients.
CAR-T cell therapy stands as a beacon of progress in medical science, acknowledged President Murmu. While this treatment has long been available in developed nations, its exorbitant cost rendered it inaccessible to many.
However, the therapy unveiled today emerges as the world’s most economically viable CAR-T cell therapy. President Murmu underlined its significance as a testament to the ‘Make in India’ initiative, epitomizing self-reliant India.
The collaborative efforts between the Indian Institute of Technology, Bombay, Tata Memorial Hospital, and industry partner ImmunoACT have yielded India’s first CAR-T cell therapy.